Effect of calcium channel blockade and beta-adrenoceptor blockade on short graded and single-level endurance exercises in normal men
- PMID: 2904883
- DOI: 10.1007/BF00636608
Effect of calcium channel blockade and beta-adrenoceptor blockade on short graded and single-level endurance exercises in normal men
Abstract
The effect of verapamil (240 mg) on exercise capacity was studied during a short graded and a single-level endurance exercise test in 12 normal volunteers; it was compared to the effects of atenolol (100 mg x day-1). Intake of verapamil, atenolol and placebo, administered according to a randomized, double-blind cross-over design, was started 3 days before the exercise tests. Compared to placebo, verapamil did not affect peak oxygen uptake in the graded test or exercise duration in the endurance test. Heart rate, systolic blood pressure, rating of perceived exertion and respiratory data at submaximal and peak exercise were unaffected in either test. On the other hand atenolol reduced maximal oxygen uptake by 5% (p less than 0.001) and endurance exercise duration by 17% (p less than 0.05). Besides marked decreases in heart rate and systolic blood pressure during the two types of exercise, atenolol also reduced oxygen uptake at submaximal exercise levels and it increased the rating of perceived exertion (p less than 0.05), the latter only during the endurance exercise test.
Similar articles
-
Beta-adrenoceptor blockade and exercise. An update.Sports Med. 1988 Apr;5(4):209-25. doi: 10.2165/00007256-198805040-00002. Sports Med. 1988. PMID: 2897710 Review.
-
Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men.J Hypertens. 2000 Jan;18(1):35-43. doi: 10.1097/00004872-200018010-00006. J Hypertens. 2000. PMID: 10678541 Clinical Trial.
-
Effect of dual beta-blockade and calcium antagonism on endurance performance.Med Sci Sports Exerc. 1987 Feb;19(1):1-6. Med Sci Sports Exerc. 1987. PMID: 2881183 Clinical Trial.
-
Physical performance and muscle metabolism during beta-adrenergic blockade in man.Acta Physiol Scand Suppl. 1984;536:1-53. Acta Physiol Scand Suppl. 1984. PMID: 6151777 Clinical Trial.
-
Exercise performance and beta-blockade.Sports Med. 1985 Nov-Dec;2(6):389-412. doi: 10.2165/00007256-198502060-00002. Sports Med. 1985. PMID: 2866577 Review.
Cited by
-
Verapamil. An updated review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension.Drugs. 1989 Jul;38(1):19-76. doi: 10.2165/00003495-198938010-00003. Drugs. 1989. PMID: 2670511 Review.
-
The effects of beta1-adrenergic blockade on cardiovascular oxygen flow in normoxic and hypoxic humans at exercise.Eur J Appl Physiol. 2005 Oct;95(2-3):250-9. doi: 10.1007/s00421-005-1393-5. Epub 2005 Oct 1. Eur J Appl Physiol. 2005. PMID: 16200423
-
Functional capacity in healthy volunteers before and following beta-blockade with controlled-release metoprolol.Eur J Clin Pharmacol. 1995;48(2):127-31. doi: 10.1007/BF00192737. Eur J Clin Pharmacol. 1995. PMID: 7589026 Clinical Trial.
-
Beta-adrenoceptor blockade and exercise. An update.Sports Med. 1988 Apr;5(4):209-25. doi: 10.2165/00007256-198805040-00002. Sports Med. 1988. PMID: 2897710 Review.
-
A Randomized Controlled Trial of R-Form Verapamil Added to Ongoing Metformin Therapy in Patients with Type 2 Diabetes.J Clin Endocrinol Metab. 2022 Sep 28;107(10):e4063-e4071. doi: 10.1210/clinem/dgac436. J Clin Endocrinol Metab. 2022. PMID: 35917580 Free PMC article. Clinical Trial.